أزينيل ٢٠٠ ملغ/٥ ملل معلق

Pays: Israël

Langue: arabe

Source: Ministry of Health

Achète-le

Notice patient Notice patient (PIL)
17-07-2023

Ingrédients actifs:

AZITHROMYCIN AS DIHYDRATE 200 MG / 5 ML

Disponible depuis:

PFIZER PHARMACEUTICALS ISRAEL LTD

Code ATC:

J01FA10

forme pharmaceutique:

POWDER FOR SUSPENSION

Mode d'administration:

PER OS

Fabriqué par:

HAUPT PHARMA LATINA S.R.L, ITALY

Groupe thérapeutique:

AZITHROMYCIN

indications thérapeutiques:

Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Date de l'autorisation:

2010-03-01

Notice patient

                                Azenil Capsules, Azenil Suspension PIL CC 160723 Technical change
2023-0086619
ةرﺷﻧ
كﻠﮭﺗﺳﻣﻠﻟ
بﺟوﻣﺑ
ﺔﻣظﻧأ
ﺔﻟدﺎﯾﺻﻟا
)
تار
َ
ﺿﺣﺗﺳﻣ
(
-
1986
ق
ّ
وﺳ
ُ
ﯾ
ءاودﻟا
ﻖﻓو
ﺔﻔﺻو
بﯾﺑط
طﻘﻓ
تﻻوﺳﺑﻛ ™لﯾﻧﯾزأ
لﯾﻧﯾزأ
™
200
ﻎﻠﻣ
/
5
ﻖﻠﻌﻣ لﻠﻣ
:ﻰﻠﻋ ﺔﻟوﺳﺑﻛ لﻛ يوﺗﺣﺗ
ﯾزأ
ﺛ
نﯾﺳﯾﻣور
)
تاردﯾﮭﯾد لﻛﺷ ﻰﻠﻋ
(
250
ﻎﻠﻣ
) 250 mg
ihydrate
d
as
(
zithromycin
a لﻛ يوﺗﺣﺗ
5
:ﻰﻠﻋ ﻖﻠﻌﻣﻟا نﻣ لﻠﻣ
ﯾزأ
ﺛ
نﯾﺳﯾﻣور
)
تاردﯾﮭﯾد لﻛﺷ ﻰﻠﻋ
(
200
ﻎﻠﻣ
) 200 mg
ihydrate
d
as
zithromycin (
a
داوﻣ
:ﺔ
ّ
ﯾﺳﺎﺳﺣﻠﻟ ةرﯾﺛﻣو ﺔﻟﺎ
ّ
ﻌﻓ رﯾﻏ
ا
رظﻧ
دﻧﺑﻟا
2
تﺣﺗ
دﻧﺑﻟاو "ءاودﻟا تﺎﺑﻛرﻣ نﻣ مﺳﻗ نﻋ
ﺔﻣﮭﻣ تﺎﻣوﻠﻌﻣ"
6
."ﺔ
ّ
ﯾﻓﺎﺿإ تﺎﻣوﻠﻌﻣ"
أرﻗا
ا ﻰﺗﺣ ن
ّ
ﻌﻣﺗﺑ ةرﺷﻧﻟ
ءاودﻟا لﺎﻣﻌﺗﺳﺎﺑ ءدﺑﻟا لﺑﻗ كﻟذو
ﺎﮭﺗﯾﺎﮭﻧ
ﻟا هذھ يوﺗﺣﺗ .
ﻧ
تﻧﺎﻛ اذإ .ءاودﻟا نﻋ ةزﺟوﻣ
تﺎﻣوﻠﻌﻣ ﻰﻠﻋ ةرﺷ
ّ
ﯾﻓﺎﺿإ ﺔﻠﺋﺳأ كﯾدﻟ
.
ّ
ﻲﻟدﯾﺻﻟا ﻰﻟإ وأ بﯾﺑطﻟا ﻰﻟإ ﮫ
ّ
ﺟوﺗﻓ ﺔ
.كﻠﺟأ نﻣ جﻼﻌﻠﻟ ءاودﻟا اذھ فﺻ
ُ
و
ِ
طﻌﺗ ﻻ
ﮫ
ﻟ
نﯾرﺧﻶ
؛
مﮭﺑ
ّ
رﺿﯾ دﻗ ﮫ
ّ
ﻧﻷ
،
نﯾﺑ ﮫﺑﺎﺷﺗ كﻟ ادﺑ وﻟ ﻰﺗﺣ
.ﺔ
ّ
ﯾﺣﺻﻟا مﮭﺗﻟﺎﺣو كﺗﻟﺎﺣ
لﯾﻧﯾزأ
200
/ﻎﻠﻣ
5
ﻖﻠﻌﻣ لﻠﻣ
رﻣﻋ نﻣ لﺎﻔطﻷ
ّ
دﻌﻣ
6
.رﮭﺷأ
تﻻوﺳﺑﻛ لﯾﻧﯾزأ
نﻣ رﺛﻛأ نوﻧزﯾ نﯾذﻟا لﺎﻔطﻷ
ّ
دﻌﻣ
45
.ﻎﻠﻛ
1 .
َ
مﻟ
؟ءاوّ
دﻟا اذھ ّ
دﻋأ
•
جﻼﻌﻟ
ىودﻌﻟا تﻻﺎﺣ
ﺔﯾﺳﻔﻧﺗﻟا قرطﻟا ﻲﻓ رﺿ
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient anglais 17-07-2023
Rapport public d'évaluation Rapport public d'évaluation anglais 14-07-2019
Notice patient Notice patient hébreu 17-07-2023